Please provide your email address to receive an email when new articles are posted on . Three measures of lung function improved between baseline and 12 months. Observed improvements were not as large ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung ...
New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...
LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...
The Study presents a novel approach to improving the global applicability of clinical trial outcomes by assessing how well results from controlled trials translate to real-world patient populations.
Registry of Genetic Alterations of Taiwan Non–Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521 Tissue inadequacy ...
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter ...
Lutathera showed antitumor activity in metastatic BP-NETs, with partial responses in 17% of patients and stable disease in 30%. The study reported a median progression-free survival of 10.8 months and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback